Last updated 29 days ago
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
240 patients around the world
Available in Spain, Argentina, United States
Incyte Corporation
5Research sites
240Patients around the world
This study is for people with
Asthma
Requirements for the patient
To 65 Years
All Gender
Medical requirements
Sites
Polo de Salud Vistalba
Centro Respiratorio Quilmes - Buenos Aires
Mautalen - Salud e Investigación - CABA
I.E.R.I.M - Instituto de Enfermedades Respiratorias e Investigación Médica - Bs As
Centro Médico Respire S.R.L. - San Fernando - Buenos Aires
SponsorIncyte Corporation
Conditions
Requirements
To 65 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05851443
